BioSpace News Archive

IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage biotechnology company, announces it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Institute of Allergy and Infectious Diseases (NIAID) to evaluate the immunogenicity and efficacy of two IMUNON DNA-based Lassa virus vaccine candidates.

Mesa Laboratories Inc, a global leader in the design and manufacturing of life science tools and critical quality control solutions, announced its commitment to calculate and disclose scope 1 and 2 greenhouse gas emissions prior to the August 2024 Annual Meeting of Shareholders as part of its sustainability roadmap.

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in the Citi Annual BioPharma Conference in Boston. Company management will participate in a fireside chat on Thursday, September 7, 2023, at 8:20 a.m. PT / 11:20 a.m. ET / 4:20 p.m. IST.

Altis Biosystems, a leader in developing innovative, in vitro cell-based model systems for drug discovery, announces the launch of RepliGut® Planar InflammaScreen™ Services.

Peak Bio, Inc., is a clinical-stage biopharmaceutical company focused on developing and commercializing the next-generation of innovative therapeutics that aim to improve and address significant unmet medical need for patients with inflammatory, rare-specialty diseases and cancer.

Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 21st annual Morgan Stanley Global Healthcare Conference in New York City. Gerald Herman, Executive Vice President & CFO will participate in a fireside chat on behalf of the Company on Wednesday, September 13th, 2023 at 4:15 PM Eastern Time.

Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, announced that management will present a company update at the following investor conferences.